← Back to Guides
Pharma & Diplomatic
May 19, 2026
IT Continuity for European-Based Pharmaceutical Laboratories in Mexico

Pharma Business Continuity: What Your European Headquarters Expects from Your Mexican IT Department

GxP, cold chain, traceability, Big Four audits. These are the non-negotiable requirements that ensure the IT VP in Lyon or Toulouse can sleep soundly.

Resource · Keptos

Why the VP of IT in Europe Is Scrutinizing Mexican IT

Whether from Lyon, Basel, or Barcelona, your European IT director doesn’t view Mexico as just another subsidiary. They see a complex regulatory landscape, a critical supply chain, and a risk point that could jeopardize the approval of an EMA, FDA COFEPRIS audit COFEPRIS a matter of weeks. When a batch is held up due to a lack of digital traceability, when a validation system fails a Big Four audit, or when temperature data from a shipment isn’t properly recorded, the impact is felt throughout the entire corporation.

The pressure faced by the IT manager of a Mexican pharmaceutical subsidiary is real and growing. The demands from the parent company are not mere bureaucratic whims: they stem from binding regulatory frameworks such as Good Manufacturing Practices (GMP), the FDA 21 CFR Part 11 requirements FDA the European guidelines for the validation of computerized systems (GAMP 5). Understanding what your headquarters expects is the first step toward moving beyond a defensive stance and beginning to operate with confidence.

Non-negotiable requirements: GxP , data traceability, system integrity

When the European headquarters refers to “IT for compliance,” it is referring to three pillars that leave no room for interpretation:

  • GxP Compliance GxP GMP): Each critical system (LIMS, MES, QMS, ERP ) must have documented validation— IQ/OQ/PQ protocols that IQ/OQ/PQ , signed, and archived, are currently valid, and have been revalidated after each significant change.
  • Data traceability according to ALCOA+: Every piece of data generated must be Attributable, Legible, Contemporary, Original, and Attributable to the owner, as well as Complete, Consistent, Permanent, and Available. This requires an active audit trail in all systems that generate GxP data GxP documented procedures for periodic review.
  • System integrity: formalized change control, segregation of duties, strict management of privileged access, and verified backups with quarterly restore tests. Without these controls, any GxP system GxP vulnerable to an audit finding.

If any of these three pillars show signs of weakness, your European headquarters will know about it before you even notice. And it will document it.

Cold Chain and IT Monitoring: What Minimum Infrastructure Does the European Headquarters Require?

Mexico is a high-risk logistics environment for the pharmaceutical sector: heat, humidity, long distances, and inconsistent infrastructure. The European headquarters is aware of this and requires a monitoring infrastructure that leaves no room for doubt:

  • Certified and calibrated sensors (temperature, humidity, shock) at every critical point: warehouses, cold storage rooms, transportation, and loading areas. Annual calibration with a certificate traceable to national standards.
  • A centralized telemetry platform with a minimum 5-year history, auditable, COFEPRIS accessible for COFEPRIS inspections COFEPRIS for real-time monitoring by headquarters.
  • Multi-channel alert system (SMS, email, phone call) with documented escalation, validated thresholds, and monthly testing of the entire alert workflow.
  • Integration with the QMS and automatic export to the European headquarters' system, with periodic data reconciliation to ensure consistency between the two repositories.

It's not just about having sensors. It's about demonstrating that the data generated is reliable, auditable, and comparable to headquarters' records. If your infrastructure can't answer that question automatically, it's an active risk.

Big Four Audits in Mexico: How to Prepare Your IT Department for a Smooth Process

Global audit firms—Deloitte, PwC, EY, and KPMG—are conducting increasingly technical reviews when auditing pharmaceutical subsidiaries in Latin America. It is no longer enough to simply demonstrate procedures: they request access to systems, review logs, verify access controls, and confirm that documented processes match what actually happens in production.

Areas where Mexican subsidiaries often fall short include: poor management of privileged access, backups without documented restoration tests, systems no longer supported by the manufacturer, and the lack of an up-to-date inventory of critical IT assets. Preparing for a Big Four audit is not a two-week sprint: it is the result of operational maturity built up over months in advance.

The checklist Keptos uses Keptos its pharma-IT assessments

After 30 years of supporting European subsidiaries in Mexico, Keptos developed a structured assessment that covers the critical areas examined by every European headquarters. This is the framework we apply:

  • Complete inventory of GxP systems GxP production (LIMS, ERP, MES, QMS, analytical systems) along with their validation status.
  • Current status of IQ/OQ/PQ protocols IQ/OQ/PQ validity of revalidations following changes.
  • ALCOA+ verification ALCOA+ critical flows: sampling and end-to-end traceability testing.
  • An active audit trail that is reviewed periodically and has a documented review procedure.
  • A formalized foreign exchange control policy, with evidence of its implementation over the past 12 months.
  • Privileged access management with documented segregation of duties and quarterly reviews.
  • Backups with documented and verified quarterly restore tests.
  • Business continuity and disaster recovery plan tested in an annual live drill.
  • Inventory, calibration, and monitoring of the cold chain and transportation, with operational alerts.
  • Consolidated documentation, ready for COFEPRIS inspections COFEPRIS Big Four audits, available in less than 48 hours.

A specialized assessment, not a generic audit

If your European office is scheduling an audit, if you've just received a corporate quality questionnaire, or if you simply know that your IT infrastructure isn't where it should be, now is the time to act.

In Keptos, we conduct pharma-IT assessments specifically designed for Mexican subsidiaries of European groups. We understand the standards your headquarters applies, the criteria used by audit firms, and the areas where local organizations are typically at risk. The result is an actionable report, in Spanish and in your corporate language, that allows you to present a concrete plan to your management.

Request your specialized Keptos assessment and turn the next audit cycle into an opportunity to demonstrate your European headquarters’ operational maturity.

Do you need specific help with this topic?

30 minutes with one of our directors. No sales pitch—straight to the point.

Free Diagnosis · 30 minQuote within 24 hours